Company Filing History:
Years Active: 2000-2003
Title: Innovations by Inventor Russ Mumper
Introduction
Russ Mumper, an accomplished inventor based in The Woodlands, TX, has significantly contributed to the field of nucleic acid delivery systems. With a total of two patents to his name, his work focuses on developing more efficient methods for plasmid delivery and storage.
Latest Patents
Mumper’s latest patents include a protected one-vial formulation for nucleic acid molecules and methods of making the same by in-line mixing. This invention pertains to incorporating plasmids into a conventional dosage form, specifically through the production of a single-vial, homogenized plasmid/polymer complex with desirable physical characteristics. The resulting products are designed to be more convenient and cost-effective, providing protection against chemical degradation and facilitating ease of administration. Additionally, his work on IL-2 gene expression and delivery systems emphasizes plasmid expression systems for delivering DNA coding sequences to mammals, incorporating specific lipid/DNA delivery systems with advantageous characteristics.
Career Highlights
Russ Mumper has had a distinguished career, having worked for companies such as Valentis, Inc. and GeneMedicine, Inc. His innovative solutions in the realm of biopharmaceuticals have advanced the way plasmids and genes are delivered and expressed in medical applications.
Collaborations
Throughout his career, Mumper has collaborated with various talented individuals, including Maria Bruno and Jenna Tagliaferri. These partnerships have enriched his research and development efforts, leading to meaningful advancements in the field.
Conclusion
Russ Mumper's contributions to the science of nucleic acid delivery exemplify the impact of innovative thinking in biotechnology. His patents not only enhance the efficiency of plasmid delivery but also pave the way for more effective treatments in the medical sector. As new methods arise from his discoveries, the future of gene therapy and biopharmaceuticals looks increasingly promising.